Contribution By Pankaj Singh
A dispatchable renewable plant in Mexico has reportedly integrated Mitsubishi Power’s TOMONITM Intelligent Digital Solutions for improving reliability and efficiency.
The 25-megawatt power station, located in Nayarit, Mexico, is the world&rsqu
BlueNalu, a cellular aquaculture company, has recently announced the Eat Blue™ Essay Contest’s winners in partnership with the RCA (Research Chefs Association). The contest had prompted discussions regarding seafood sustainability & t
American energy frontrunner, NextEra Energy Partners, LP has recently signed a definitive agreement with Canada-based renewable power operator, Brookfield Renewable to acquire its 391-megawatt (MW) portfolio consisting of four operating wind assets.
Renesas Electronics Corporation, a semiconductor manufacturing company, has recently joined the RBA (Responsible Business Alliance). As a member of the RBA, the company is planning to support the vision and goals of RBA to develop environmentally res
Borealis Group AG, a chemical company, has reportedly initiated a new project to secure a high supply of chemically-recycled feedstock to produce more circular base chemicals & polyolefin-based products. A feasibility study has already begun for
Vadilal Group, an ice cream & flavored milk manufacturer, is reportedly eyeing to reach over 800 crore ($106.7 million) sales from ice creams in India in the fiscal year 2021. The anticipated rise in product sales will be driven by the strong pro
U.S. government scientists are reportedly inspecting two COVID-19 vaccines for possibly rare blood clotting scenarios identified in brains. These scientists are focusing on whether a specific technology used for producing these shots may be causing t
Global technology giant, Microsoft, is reportedly planning to take over artificial intelligence firm, Nuance Communications, for close to $16 billion. For the record, the AI company’s speech recognition technology has supported the development
BeiGene, Ltd., a biotechnology company, has recently gained approval from the China NMPA (National Medical Products Administration) to start the commercial supply of tislelizumab.
Tislelizumab will be produced at its state-of-the-art biologics plant